Butyl (1S,2R,3S,4R,5S)-4-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9H-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylate

ID: ALA4068757

Chembl Id: CHEMBL4068757

PubChem CID: 137633306

Max Phase: Preclinical

Molecular Formula: C23H24ClN5O4S

Molecular Weight: 502.00

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CCCCOC(=O)[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC)nc(C#Cc4ccc(Cl)s4)nc31)[C@H](O)[C@@H]2O

Standard InChI:  InChI=1S/C23H24ClN5O4S/c1-3-4-9-33-22(32)23-10-13(23)17(18(30)19(23)31)29-11-26-16-20(25-2)27-15(28-21(16)29)8-6-12-5-7-14(24)34-12/h5,7,11,13,17-19,30-31H,3-4,9-10H2,1-2H3,(H,25,27,28)/t13-,17-,18+,19+,23+/m1/s1

Standard InChI Key:  FJRJLQWNWPJFCU-VYYPKGNMSA-N

Alternative Forms

1. Parent:

   

   ALA4068757

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 502.00

Molecular Weight (Monoisotopic): 501.1238

AlogP: 2.61

#Rotatable Bonds: 6

Polar Surface Area: 122.39

Molecular Species: NEUTRAL

HBA: 10

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 9

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 13.12

CX Basic pKa: 3.41

CX LogP: 3.35

CX LogD: 3.35

Aromatic Rings: 3

Heavy Atoms: 34

QED Weighted: 0.27

Np Likeness Score: 0.18

References

1. Tosh DK, Janowsky A, Eshleman AJ, Warnick E, Gao ZG, Chen Z, Gizewski E, Auchampach JA, Salvemini D, Jacobson KA..  (2017)  Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters.,  60  (7): [PMID:28319392] [10.1021/acs.jmedchem.7b00141]

Source

Source(1):

• Scientific Literature